First Trust Advisors LP Eton Pharmaceuticals, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$4.96 - $9.06 $139,276 - $254,404	-28,080 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$3.5 - $6.09 $27,429 - $47,727	7,837 Added 38.71%	28,080 $153,000
Q1 2020 May 06, 2020	SELL	$2.87 - $7.47 $11,264 - $29,319	-3,925 Reduced 16.24%	20,243 $83,000
Q4 2019 Feb 03, 2020	SELL	$5.59 - $7.2 $2,308 - $2,973	-413 Reduced 1.68%	24,168 $174,000
Q3 2019 Nov 04, 2019	BUY	$5.19 - $8.72 $127,575 - $214,346	24,581 New	24,581 $155,000

9.03M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $442M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.